[go: up one dir, main page]

UY37729A - NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7 - Google Patents

NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7

Info

Publication number
UY37729A
UY37729A UY0001037729A UY37729A UY37729A UY 37729 A UY37729 A UY 37729A UY 0001037729 A UY0001037729 A UY 0001037729A UY 37729 A UY37729 A UY 37729A UY 37729 A UY37729 A UY 37729A
Authority
UY
Uruguay
Prior art keywords
activity
inhibit
new compounds
therapy
treatment
Prior art date
Application number
UY0001037729A
Other languages
Spanish (es)
Inventor
Xin Hao
Xin Ma
Feng Ren
Zehong Wan
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of UY37729A publication Critical patent/UY37729A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos que inhiben la actividad de Nav1,7, a composiciones farmacéuticas que los contienen y a su uso en terapia para el tratamiento de enfermedades mediadas por la actividad de Nav1,7.The present invention relates to new compounds that inhibit the activity of Nav1.7, pharmaceutical compositions containing them and their use in therapy for the treatment of diseases mediated by the activity of Nav1.7.

UY0001037729A 2017-05-11 2018-05-09 NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7 UY37729A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2017083938 2017-05-11

Publications (1)

Publication Number Publication Date
UY37729A true UY37729A (en) 2019-01-02

Family

ID=64104337

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037729A UY37729A (en) 2017-05-11 2018-05-09 NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7

Country Status (4)

Country Link
AR (1) AR112187A1 (en)
TW (1) TW201908310A (en)
UY (1) UY37729A (en)
WO (1) WO2018205948A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020199683A1 (en) * 2019-04-04 2020-10-08 上海海雁医药科技有限公司 Nitrogen heterocycle substituted sulfonylbenzamide derivative, preparation method therefor and use thereof in medicine
CN118812481A (en) 2019-08-23 2024-10-22 持田制药株式会社 Method for producing heterocyclic acetamide derivatives
EP4019485B1 (en) 2019-08-23 2024-08-07 Mochida Pharmaceutical Co., Ltd. Method for producing heterocyclidene acetamide derivatives
CN112028816B (en) * 2020-09-11 2022-10-14 江阴迈康升华医药科技有限公司 Synthesis method of substituted isoindoline
WO2023028056A1 (en) 2021-08-24 2023-03-02 Genentech, Inc. 3-amino piperidyl sodium channel inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2427441B1 (en) * 2009-05-04 2016-12-14 Agios Pharmaceuticals, Inc. Pkm2 activators for use in the treatment of cancer
CA2852796A1 (en) * 2011-10-28 2013-05-02 Merck Sharp & Dohme Corp. Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
BR112015009216A2 (en) * 2012-10-26 2017-07-04 Merck Sharp & Dohme compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of a pharmaceutical composition

Also Published As

Publication number Publication date
AR112187A1 (en) 2019-10-02
WO2018205948A1 (en) 2018-11-15
TW201908310A (en) 2019-03-01

Similar Documents

Publication Publication Date Title
DOP2019000005A (en) 3-METIL PIRAZINAS 2,5-DISUSTITUIDAS AND 3-METIL PIRAZINAS 2,5,6-TRISUSTITUIDAS AS ALLOSTERIC INHIBITORS OF SHP2
ECSP20033467A (en) MACROCYCLIC COMPOUNDS TO TREAT DISEASES
CL2018001685A1 (en) Heterocyclic compounds as immuno modulators.
CO2017011851A2 (en) Novel compounds
UY37617A (en) MODULATORS OF THE REGULATORY PROTEIN OF TRANSMEMBRANE CONDUCTANCE IN CHYSICAL FIBROSIS AND EMPLOYMENT METHODS
GT201600147A (en) DERIVATIVE COMPOUNDS AND COMPOSITIONS OF N-AZASPIROCICLOALCANO N-HETEROARIL REPLACED TO INHIBIT THE ACTIVITY OF SHP2
CR20160518A (en) COMPOUNDS TO TREAT SPINAL MUSCLE ATROPHY
UY36224A (en) TRICYCLIC COMPOUNDS OF IMIDAZO-PIRIMIDINONA
MX2019012847A (en) C5-anilinoquinazoline compounds and their use in treating cancer.
MX2016011810A (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE.
CL2021001395A1 (en) Compounds derived from cyclic pantheines; pharmaceutical composition comprising them; and its use to increase the concentrations of acetyl-coa, for the treatment of cancer, inflammatory disease, neurodegenerative disease, multiple sclerosis, among other diseases.
CU20190101A7 (en) SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES
CL2019001658A1 (en) Tricyclic enone pyrimidine derivatives for rory inhibition and other uses.
UY36875A (en) BROMODOMINIUM INHIBITING COMPOSITIONS FOR THE TREATMENT OF VARIOUS DISEASES
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
CL2021001388A1 (en) Useful compounds in hiv therapy
MX2021004566A (en) THERAPEUTIC COMPOUNDS.
CL2017001073A1 (en) 2,4 diamino-quinolia substituted as new anticancer agents
UY37729A (en) NEW COMPOUNDS THAT INHIBIT THE ACTIVITY OF Nav1.7
CL2015000039A1 (en) Estra-1,3,5 (10), 16-tetraeno-3-substituted derivatives, pharmaceutical preparations that comprise them and their use in the preparation of medicaments for treating endometriosis.
DOP2016000297A (en) PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES
MX2020012058A (en) TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER.
MX2021015770A (en) MACROCYCLIC MCL-1 INHIBITORS.
CL2019002480A1 (en) Pyrazole derivatives as bromodomain inhibitors.
MX2020004678A (en) USE OF RILUZOL PRODRUGS TO TREAT ATAXIAS.